Fig. 7.
Preparation of PM-NP-DOX, evaluation of tumor-specific targeting ability, and inhibition of tumor growth. (A) MSC membrane-shrouded polymeric PLGA nanoplatform for tumor-specific DOX delivery. (B) Tumor-specific targeting capability between lipo-NP and PM-NP groups. (C) Tumor inhibition efficacy after different treatments. PM: cell plasma membrane. Reproduced with permission from [112]. Copyright 2018 American Chemical Society.